CSF3 and breast cancer: Using two syngeneic solid tumour models, a 4T1 breast cancer model and a CT26 colorectal cancer model, our workflow revealed that myeloid factors in the blood, such as neutrophils, monocytes and the levels of the myeloid cell-propagator G-CSF, feature prominently as key determinants of tumour classification (Fig 2).